Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials

ABSTRACT Biofilms are considered to be highly resistant to antimicrobial agents. Strictly speaking, this is not the case—biofilms do not grow in the presence of antimicrobials any better than do planktonic cells. Biofilms are indeed highly resistant to killing by bactericidal antimicrobials, compared to logarithmic-phase planktonic cells, and therefore exhibit tolerance. It is assumed that biofilms are also significantly more tolerant than stationary-phase planktonic cells. A detailed comparative examination of tolerance of biofilms versus stationary- and logarithmic-phase planktonic cells with four different antimicrobial agents was performed in this study. Carbenicillin appeared to be completely ineffective against both stationary-phase cells and biofilms. Killing by this β-lactam antibiotic depends on rapid growth, and this result confirms the notion of slow-growing biofilms resembling the stationary state. Ofloxacin is a fluoroquinolone antibiotic that kills nongrowing cells, and biofilms and stationary-phase cells were comparably tolerant to this antibiotic. The majority of cells in both populations were eradicated at low levels of ofloxacin, leaving a fraction of essentially invulnerable persisters. The bulk of the population in both biofilm and stationary-phase cultures was tolerant to tobramycin. At very high tobramycin concentrations, a fraction of persister cells became apparent in stationary-phase culture. Stationary-phase cells were more tolerant to the biocide peracetic acid than were biofilms. In general, stationary-phase cells were somewhat more tolerant than biofilms in all of the cases examined. We concluded that, at least forPseudomonas aeruginosa, one of the model organisms for biofilm studies, the notion that biofilms have greater resistance than do planktonic cells is unwarranted. We further suggest that tolerance to antibiotics in stationary-phase or biofilm cultures is largely dependent on the presence of persister cells.

[1]  I. Chopra,et al.  Joint Tolerance to β-Lactam and Fluoroquinolone Antibiotics in Escherichia coli Results from Overexpression of hipA , 1998, Antimicrobial Agents and Chemotherapy.

[2]  A. Tomasz,et al.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. , 1986, Journal of general microbiology.

[3]  R. Kolter,et al.  Biofilm formation as microbial development. , 2000, Annual review of microbiology.

[4]  P. Watnick,et al.  Steps in the development of a Vibrio cholerae El Tor biofilm , 1999, Molecular microbiology.

[5]  A. Brooun,et al.  A Dose-Response Study of Antibiotic Resistance inPseudomonas aeruginosa Biofilms , 2000, Antimicrobial Agents and Chemotherapy.

[6]  Roberto Kolter,et al.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.

[7]  K. Lewis,et al.  Programmed Death in Bacteria , 2000, Microbiology and Molecular Biology Reviews.

[8]  H. Ceri,et al.  Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms , 2001, Antimicrobial Agents and Chemotherapy.

[9]  H. Anwar,et al.  Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. , 1989, The Journal of antimicrobial chemotherapy.

[10]  R. Kolter,et al.  Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development , 1998, Molecular microbiology.

[11]  M. R. Brown,et al.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response , 1990, Antimicrobial Agents and Chemotherapy.

[12]  H. Moyed,et al.  hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis , 1983, Journal of bacteriology.

[13]  P. Stewart,et al.  Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin , 2000, Antimicrobial Agents and Chemotherapy.

[14]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[15]  M. Mardis,et al.  Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis , 1991, Journal of bacteriology.

[16]  P. Gilbert,et al.  Biofilm Susceptibility to Antimicrobials , 1997, Advances in dental research.

[17]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[18]  B. Irwin,et al.  Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis , 1994, Journal of bacteriology.

[19]  J. Costerton,et al.  Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.

[20]  M. R. Brown,et al.  Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. , 1998, The Journal of antimicrobial chemotherapy.

[21]  H. Ceri,et al.  The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms , 1999, Journal of Clinical Microbiology.

[22]  G. Peters,et al.  New Aspects in the Molecular Basis of Polymer-Associated Infections due to Staphylococci , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  J. Bigger.  TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION , 1944 .

[24]  H. Moyed,et al.  Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12 , 1988, Journal of bacteriology.

[25]  Tsuyoshi Otani,et al.  In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.

[26]  H. Moyed,et al.  Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis , 1986, Journal of bacteriology.

[27]  P. Genevaux,et al.  A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. , 1996, FEMS microbiology letters.

[28]  D. Hooper,et al.  Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents , 1990, Antimicrobial Agents and Chemotherapy.

[29]  P. Stewart,et al.  Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics , 1997, Antimicrobial agents and chemotherapy.

[30]  K. Lewis,et al.  Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[31]  M. Schulz,et al.  Therapeutic and toxic blood concentrations of more than 500 drugs. , 1997, Die Pharmazie.

[32]  M. Sugai,et al.  Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. , 1997, Chemotherapy.

[33]  R. Kolter,et al.  Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.

[34]  Nichols,et al.  Inhibition of tobramycin diffusion by binding to alginate , 1988, Antimicrobial Agents and Chemotherapy.

[35]  J. Costerton,et al.  The biofilm glycocalyx as a resistance factor. , 1990, The Journal of antimicrobial chemotherapy.

[36]  D. Allison,et al.  An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. , 2000, The Journal of antimicrobial chemotherapy.

[37]  N. Hodges,et al.  Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. , 1988, The Journal of antimicrobial chemotherapy.